New Horizons Diagnostics Corp
34Patents
0Active
34Granted
36Portfolio score
Filing activity: Mar 27, 1985 → Nov 25, 2003
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US4770853A | Device for self contained solid phase immunodiffusion assay | Performing Operations; Transporting | 165 | Expired |
| US5169789A | Device and method for self contained solid phase immunodiffusion assay | Human Necessities | 78 | Expired |
| US5985271A | Prophylactic and theraputic treatment of group A streptococcal infection | Chemistry; Metallurgy | 51 | Expired |
| US6056954A | Use of bacterial phage associated lysing enzymers for the prophylactic and therapeutic treatment of various illnesses | Emerging Cross-Sectional Technologies | 50 | Expired |
| US5604109A | Method for exposing Group A streptococcal antigens and an improved diagnostic test for the identification of Group A streptococci | Emerging Cross-Sectional Technologies | 46 | Expired |
| US6254866A | Use of phage associated lytic enzymes for treating bacterial infections of the digestive tract | Emerging Cross-Sectional Technologies | 44 | Expired |
| US6017528A | Therapeutic treatment of group A streptococcal infections | Human Necessities | 43 | Expired |
| US5997862A | Therapeutic treatment of group A streptococcal infections | Chemistry; Metallurgy | 37 | Expired |
| US4704355A | Assay utilizing ATP encapsulated within liposome particles | Emerging Cross-Sectional Technologies | 35 | Expired |
| US6238661A | Use of bacterial phage associated lysing enzymes for treating various illnesses | Emerging Cross-Sectional Technologies | 32 | Expired |
| US6432444B1 | Use of bacterial phage associated lysing enzymes for treating dermatological infections | Human Necessities | 32 | Expired |
| US6326002A | Use of bacterial phage associated lysing enzymes for treating streptococcal infections of the upper respiratory tract | Chemistry; Metallurgy | 29 | Expired |
| US5624810A | Method for detection of surfaces contaminants | Emerging Cross-Sectional Technologies | 29 | Expired |
| US6395504B1 | Use of phage associated lytic enzymes for the rapid detection of bacterial contaminants | Chemistry; Metallurgy | 24 | Expired |
| US5393658A | Immunoassay method for the rapid identification of detergent treated antigens | Emerging Cross-Sectional Technologies | 20 | Expired |
| US5736351A | Method for detection of contaminants | Emerging Cross-Sectional Technologies | 19 | Expired |
| US6936244B2 | Use of bacterial phage associated lysing enzymes for treating streptococcal infections of the upper respiratory tract | Emerging Cross-Sectional Technologies | 12 | Expired |
| US6737079B2 | Bandage composition containing a phage associated lytic enzyme | Chemistry; Metallurgy | 9 | Expired |
| US7063837B2 | Syrup composition containing phage associated lytic enzymes | Human Necessities | 9 | Expired |
| US7169408B2 | Bandage composition containing phage associated lytic enzymes useful for treating dermatological infections | Chemistry; Metallurgy | 8 | Expired |
| US7141241B2 | Use of bacterial phage associated lysing enzymes for treating upper respiratory illnesses | Emerging Cross-Sectional Technologies | 7 | Expired |
| US6685937B2 | Chewing gum containing phage associated lytic enzymes for treating streptococcal A infections | Emerging Cross-Sectional Technologies | 6 | Expired |
| US6399097B1 | Composition for treatment of a bacterial infection of the digestive tract | Emerging Cross-Sectional Technologies | 6 | Expired |
| US6406692B1 | Composition for treatment of an ocular bacterial infection | Emerging Cross-Sectional Technologies | 6 | Expired |
| US6399098B1 | Composition for treating dental caries caused by streptococcus mutans | Emerging Cross-Sectional Technologies | 5 | Expired |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.